Bruker Corporation (BRKR)
USD 36.32
(-3.56%)
USD 36.32
(-3.56%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.83 Billion USD | 14.07% |
| 2022 | 2.48 Billion USD | -3.06% |
| 2021 | 2.56 Billion USD | 23.79% |
| 2020 | 2.07 Billion USD | 11.75% |
| 2019 | 1.85 Billion USD | 51.57% |
| 2018 | 1.22 Billion USD | 0.7% |
| 2017 | 1.21 Billion USD | 8.5% |
| 2016 | 1.11 Billion USD | 12.2% |
| 2015 | 998 Million USD | -8.7% |
| 2014 | 1.09 Billion USD | -3.95% |
| 2013 | 1.13 Billion USD | -0.76% |
| 2012 | 1.14 Billion USD | 5.64% |
| 2011 | 1.08 Billion USD | 6.18% |
| 2010 | 1.02 Billion USD | 35.74% |
| 2009 | 753.2 Million USD | -6.27% |
| 2008 | 803.6 Million USD | 173.32% |
| 2007 | 294.01 Million USD | 21.75% |
| 2006 | 241.48 Million USD | 57.98% |
| 2005 | 152.85 Million USD | -0.8% |
| 2004 | 154.07 Million USD | 3.77% |
| 2003 | 148.48 Million USD | 93.53% |
| 2002 | 76.72 Million USD | 24.7% |
| 2001 | 61.52 Million USD | 1.9% |
| 2000 | 60.38 Million USD | 5.47% |
| 1999 | 57.25 Million USD | 7.01% |
| 1998 | 53.5 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 4.28 Billion USD | 4.7% |
| 2024 Q1 | 3.05 Billion USD | 7.72% |
| 2024 Q2 | 4.07 Billion USD | 33.46% |
| 2023 Q2 | 2.59 Billion USD | 1.62% |
| 2023 FY | 2.83 Billion USD | 14.07% |
| 2023 Q1 | 2.55 Billion USD | 2.67% |
| 2023 Q3 | 2.57 Billion USD | -0.79% |
| 2023 Q4 | 2.83 Billion USD | 10.2% |
| 2022 Q4 | 2.48 Billion USD | 4.34% |
| 2022 FY | 2.48 Billion USD | -3.06% |
| 2022 Q1 | 2.52 Billion USD | -1.44% |
| 2022 Q2 | 2.39 Billion USD | -5.31% |
| 2022 Q3 | 2.38 Billion USD | -0.46% |
| 2021 Q4 | 2.56 Billion USD | 25.97% |
| 2021 FY | 2.56 Billion USD | 23.79% |
| 2021 Q2 | 2.07 Billion USD | 0.9% |
| 2021 Q3 | 2.03 Billion USD | -1.7% |
| 2021 Q1 | 2.05 Billion USD | -0.92% |
| 2020 Q2 | 2.03 Billion USD | -0.02% |
| 2020 Q1 | 2.03 Billion USD | 9.86% |
| 2020 Q3 | 1.91 Billion USD | -5.9% |
| 2020 Q4 | 2.07 Billion USD | 8.12% |
| 2020 FY | 2.07 Billion USD | 11.75% |
| 2019 Q1 | 1.32 Billion USD | 7.94% |
| 2019 Q4 | 1.85 Billion USD | 23.84% |
| 2019 Q3 | 1.49 Billion USD | 1.2% |
| 2019 FY | 1.85 Billion USD | 51.57% |
| 2019 Q2 | 1.47 Billion USD | 12.03% |
| 2018 FY | 1.22 Billion USD | 0.7% |
| 2018 Q2 | 1.02 Billion USD | -1.87% |
| 2018 Q3 | 1.06 Billion USD | 4.23% |
| 2018 Q4 | 1.22 Billion USD | 15.0% |
| 2018 Q1 | 1.04 Billion USD | -14.39% |
| 2017 Q3 | 1.22 Billion USD | 6.24% |
| 2017 FY | 1.21 Billion USD | 8.5% |
| 2017 Q4 | 1.21 Billion USD | -0.54% |
| 2017 Q1 | 1.1 Billion USD | -1.03% |
| 2017 Q2 | 1.14 Billion USD | 3.74% |
| 2016 FY | 1.11 Billion USD | 12.2% |
| 2016 Q2 | 1.05 Billion USD | 1.88% |
| 2016 Q3 | 1.09 Billion USD | 4.47% |
| 2016 Q1 | 1.03 Billion USD | 3.28% |
| 2016 Q4 | 1.11 Billion USD | 2.08% |
| 2015 Q2 | 1.05 Billion USD | 0.17% |
| 2015 Q4 | 998 Million USD | -7.15% |
| 2015 Q3 | 1.07 Billion USD | 2.09% |
| 2015 FY | 998 Million USD | -8.7% |
| 2015 Q1 | 1.05 Billion USD | -3.84% |
| 2014 Q2 | 1.11 Billion USD | -3.53% |
| 2014 Q4 | 1.09 Billion USD | -0.4% |
| 2014 Q3 | 1.09 Billion USD | -1.88% |
| 2014 Q1 | 1.15 Billion USD | 1.87% |
| 2014 FY | 1.09 Billion USD | -3.95% |
| 2013 Q2 | 1.07 Billion USD | -3.59% |
| 2013 Q3 | 1.15 Billion USD | 7.09% |
| 2013 FY | 1.13 Billion USD | -0.76% |
| 2013 Q1 | 1.11 Billion USD | -2.4% |
| 2013 Q4 | 1.13 Billion USD | -1.51% |
| 2012 Q3 | 1.1 Billion USD | -0.38% |
| 2012 FY | 1.14 Billion USD | 5.64% |
| 2012 Q2 | 1.1 Billion USD | -2.35% |
| 2012 Q4 | 1.14 Billion USD | 3.85% |
| 2012 Q1 | 1.13 Billion USD | 4.57% |
| 2011 FY | 1.08 Billion USD | 6.18% |
| 2011 Q3 | 1.06 Billion USD | -0.17% |
| 2011 Q2 | 1.06 Billion USD | 1.59% |
| 2011 Q1 | 1.05 Billion USD | 2.93% |
| 2011 Q4 | 1.08 Billion USD | 1.71% |
| 2010 Q1 | 741.7 Million USD | -1.53% |
| 2010 FY | 1.02 Billion USD | 35.74% |
| 2010 Q4 | 1.02 Billion USD | 30.56% |
| 2010 Q3 | 783.1 Million USD | 7.58% |
| 2010 Q2 | 727.9 Million USD | -1.86% |
| 2009 Q1 | 761.3 Million USD | -5.26% |
| 2009 Q4 | 753.2 Million USD | 0.33% |
| 2009 Q3 | 750.7 Million USD | -0.04% |
| 2009 FY | 753.2 Million USD | -6.27% |
| 2009 Q2 | 751 Million USD | -1.35% |
| 2008 Q1 | 1.1 Billion USD | 276.53% |
| 2008 Q3 | 782.33 Million USD | -9.23% |
| 2008 Q4 | 803.6 Million USD | 2.72% |
| 2008 Q2 | 861.86 Million USD | -22.15% |
| 2008 FY | 803.6 Million USD | 173.32% |
| 2007 Q3 | 259.84 Million USD | 8.8% |
| 2007 Q2 | 238.83 Million USD | -3.9% |
| 2007 FY | 294.01 Million USD | 21.75% |
| 2007 Q1 | 248.51 Million USD | 2.91% |
| 2007 Q4 | 294.01 Million USD | 13.15% |
| 2006 FY | 241.48 Million USD | 57.98% |
| 2006 Q4 | 241.48 Million USD | 3.69% |
| 2006 Q3 | 232.89 Million USD | 44.07% |
| 2006 Q2 | 161.65 Million USD | 2.57% |
| 2006 Q1 | 157.6 Million USD | 3.11% |
| 2005 Q1 | 155 Million USD | 0.6% |
| 2005 Q2 | 143.39 Million USD | -7.49% |
| 2005 FY | 152.85 Million USD | -0.8% |
| 2005 Q4 | 152.85 Million USD | 5.83% |
| 2005 Q3 | 144.42 Million USD | 0.72% |
| 2004 FY | 154.07 Million USD | 3.77% |
| 2004 Q1 | 144.31 Million USD | -2.81% |
| 2004 Q2 | 138.13 Million USD | -4.28% |
| 2004 Q3 | 145.2 Million USD | 5.12% |
| 2004 Q4 | 154.07 Million USD | 6.11% |
| 2003 Q1 | 84.81 Million USD | 10.55% |
| 2003 Q4 | 148.48 Million USD | 3.14% |
| 2003 Q3 | 143.95 Million USD | 66.93% |
| 2003 Q2 | 86.23 Million USD | 1.67% |
| 2003 FY | 148.48 Million USD | 93.53% |
| 2002 Q2 | 72.28 Million USD | 9.65% |
| 2002 Q1 | 65.92 Million USD | 7.14% |
| 2002 FY | 76.72 Million USD | 24.7% |
| 2002 Q4 | 76.72 Million USD | 11.5% |
| 2002 Q3 | 68.81 Million USD | -4.8% |
| 2001 Q3 | 61.11 Million USD | -0.13% |
| 2001 FY | 61.52 Million USD | 1.9% |
| 2001 Q4 | 61.52 Million USD | 0.68% |
| 2001 Q2 | 61.19 Million USD | -2.11% |
| 2001 Q1 | 62.51 Million USD | 3.52% |
| 2000 Q4 | 60.38 Million USD | 13.02% |
| 2000 Q1 | 61.48 Million USD | 0.0% |
| 2000 FY | 60.38 Million USD | 5.47% |
| 2000 Q2 | 61.5 Million USD | 0.02% |
| 2000 Q3 | 53.42 Million USD | -13.13% |
| 1999 FY | 57.25 Million USD | 7.01% |
| 1998 FY | 53.5 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -5434.397% |
| BrainsWay Ltd. | 15.31 Million USD | -18422.92% |
| Cerus Corporation | 144.3 Million USD | -1865.711% |
| Envoy Medical, Inc. | 9.4 Million USD | -30070.177% |
| electroCore, Inc. | 8.94 Million USD | -31611.571% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -52999.963% |
| IceCure Medical Ltd | 4.24 Million USD | -66690.676% |
| Inogen, Inc. | 121.38 Million USD | -2236.92% |
| OrthoPediatrics Corp. | 72.56 Million USD | -3809.263% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -9489.263% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -89046.789% |
| MaxCyte, Inc. | 36.1 Million USD | -7756.094% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -153403.147% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -666894.293% |
| Orthofix Medical Inc. | 326.58 Million USD | -768.564% |
| PAVmed Inc | 57.13 Million USD | -4864.559% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -11040.086% |
| RxSight, Inc. | 22.18 Million USD | -12684.388% |
| Sight Sciences, Inc. | 46.43 Million USD | -6008.623% |
| SI-BONE, Inc. | 61.05 Million USD | -4546.355% |
| TELA Bio, Inc. | 59.16 Million USD | -4694.227% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -2388.922% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -27389.098% |
| Acutus Medical, Inc. | 54.83 Million USD | -5072.596% |
| Talis Biomedical Corporation | 29.22 Million USD | -9606.406% |
| Spectral AI, Inc. | 12.4 Million USD | -22773.962% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -12161.606% |
| CVRx, Inc. | 39.28 Million USD | -7121.119% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -23621.203% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -116666.147% |
| Bioventus Inc. | 589.79 Million USD | -380.949% |
| Venus Concept Inc. | 107.1 Million USD | -2548.479% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -5390.583% |
| LivaNova PLC | 1.15 Billion USD | -146.247% |
| 908 Devices Inc. | 37.49 Million USD | -7466.284% |
| Alphatec Holdings, Inc. | 703.48 Million USD | -303.219% |
| Nemaura Medical Inc. | 26.37 Million USD | -10653.89% |
| NeuroPace, Inc. | 86.99 Million USD | -3160.572% |
| LENSAR, Inc. | 22.4 Million USD | -12558.307% |
| Apyx Medical Corporation | 52.31 Million USD | -5321.843% |
| Cutera, Inc. | 518.12 Million USD | -447.478% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -9571.986% |
| BioSig Technologies, Inc. | 4.68 Million USD | -60446.425% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -4759.938% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -13100.856% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | -29.283% |
| Axonics, Inc. | 82.35 Million USD | -3344.189% |
| Outset Medical, Inc. | 190.91 Million USD | -1385.792% |
| IRIDEX Corporation | 24.91 Million USD | -11285.566% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -2188.227% |
| IRadimed Corporation | 20.73 Million USD | -13579.635% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -169350.418% |
| INVO Bioscience, Inc. | 19.99 Million USD | -14086.574% |
| Telesis Bio, Inc. | 40.87 Million USD | -6840.034% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -6854.116% |
| Varex Imaging Corporation | 668.6 Million USD | -324.26% |
| Quipt Home Medical Corp. | 136.29 Million USD | -1981.251% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -79312.094% |
| Pulmonx Corporation | 60.63 Million USD | -4578.079% |
| Dynatronics Corporation | 11.78 Million USD | -23979.561% |
| Modular Medical, Inc. | 2.27 Million USD | -124750.352% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -69698.228% |
| Semler Scientific, Inc. | 6.27 Million USD | -45140.829% |
| InMode Ltd. | 75.91 Million USD | -3636.597% |
| Cytosorbents Corporation | 29.98 Million USD | -9359.915% |
| DexCom, Inc. | 4.19 Billion USD | 32.396% |
| Align Technology, Inc. | 2.45 Billion USD | -15.62% |
| Viveve Medical, Inc. | 10.84 Million USD | -26051.009% |
| ZimVie Inc. | 795.85 Million USD | -256.423% |
| Movano Inc. | 5.97 Million USD | -47398.326% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -2611.725% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -666894.293% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -23621.203% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | -343.894% |
| Profound Medical Corp. | 12.66 Million USD | -22295.63% |
| Insulet Corporation | 1.85 Billion USD | -52.875% |
| enVVeno Medical Corporation | 2.43 Million USD | -116392.813% |
| Surmodics, Inc. | 65.82 Million USD | -4209.436% |
| iCAD, Inc. | 8 Million USD | -35353.073% |
| Nuwellis, Inc. | 6.78 Million USD | -41737.758% |
| Biotricity, Inc. | 35.91 Million USD | -7797.116% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -1171.75% |
| Aethlon Medical, Inc. | 2.47 Million USD | -114295.177% |
| InspireMD, Inc. | 8.14 Million USD | -34739.11% |
| PAVmed Inc. | 57.13 Million USD | -4864.559% |
| BIOLASE, Inc. | 35.34 Million USD | -7924.782% |
| Beyond Air, Inc. | 29.77 Million USD | -9426.784% |
| FONAR Corporation | 57.45 Million USD | -4836.86% |
| AxoGen, Inc. | 101.16 Million USD | -2704.017% |
| Vivani Medical, Inc. | 25.03 Million USD | -11230.085% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -3130.899% |
| Inari Medical, Inc. | 209.32 Million USD | -1255.118% |
| UFP Technologies, Inc. | 118.04 Million USD | -2302.982% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -22252.164% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -129673.283% |
| Tenon Medical, Inc. | 5.56 Million USD | -50853.835% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -159349.129% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -15985.865% |
| AdaptHealth Corp. | 3.15 Billion USD | 10.039% |
| Sintx Technologies, Inc. | 6.59 Million USD | -42924.42% |
| NanoVibronix, Inc. | 2.68 Million USD | -105506.85% |
| Quanterix Corporation | 78.08 Million USD | -3532.754% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -79312.094% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -57967.554% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | -171.521% |
| TransMedics Group, Inc. | 568.84 Million USD | -398.66% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -16903.956% |
| NeuroMetrix, Inc. | 1.33 Million USD | -212678.406% |
| Hyperfine, Inc. | 9.8 Million USD | -28844.898% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -1033.525% |
| Biomerica, Inc. | 2.66 Million USD | -106418.964% |
| Bone Biologics Corporation | 831.4 Thousand USD | -341082.725% |
| AVITA Medical, Inc. | 19.86 Million USD | -14179.096% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -143621.155% |
| Silk Road Medical, Inc | 114.15 Million USD | -2384.802% |